1X Technologies Prepares for Home Testing of NEO Gamma Humanoid Robot in Hundreds of Households

Oslo, Norway – 1X Technologies, an AI robotics company backed by OpenAI, is preparing to deploy its latest humanoid robot, NEO Gamma, for in-home testing in several hundred households starting in 2025. This significant step towards integrating advanced robotics into daily life has garnered anticipation, notably from futurist and entrepreneur Peter H. Diamandis, MD, who tweeted, "SO much consideration is going into these products…can’t wait to own one @BerntBornich @1x_tech."

The NEO Gamma, a successor to the NEO Beta, is specifically engineered for domestic environments. Its design prioritizes safety and user-friendliness, featuring soft covers, a minimalist aesthetic, and Emotive Ear Rings for intuitive feedback. CEO Bernt Børnich emphasized that the robot's development is deeply considerate of life at home, aiming for seamless integration rather than disruption.

Key advancements in NEO Gamma include a multipurpose whole-body controller, enabling a natural human gait, squats, and sitting. The robot also boasts improved general-purpose manipulation for handling various objects and integrates a new in-house language model for natural conversation. These AI enhancements are designed to allow NEO Gamma to learn and adapt to the diverse real-world contexts of a home.

1X Technologies' strategy contrasts with many competitors focusing on industrial applications, as the company aims to bring versatile, intelligent humanoids directly into consumer households. The in-home testing phase is crucial for collecting diverse data, which 1X believes is essential for the robots to achieve full autonomy and perform a wide range of tasks effectively.

The company, co-headquartered in San Francisco Bay and Norway, secured significant funding, including a round led by OpenAI, underscoring the strategic importance of its mission to create an abundant supply of physical labor through safe, intelligent humanoids. The endorsement from figures like Dr. Diamandis highlights the growing interest and potential impact of these domestic robotic companions.